FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/06/053405 [Registered on: 01/06/2023] Trial Registered Prospectively
Last Modified On: 01/06/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Clinical study of Meshashrungyadi kashaya and Rasna guggul in the management of Gridhrasi w.s.r. to Sciatica Neuritis. 
Scientific Title of Study   Comparative clinical study of Meshashrungyadi kashaya and Rasna guggul in the management of Gridhrasi w.s.r. to Sciatica Neuritis. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Manohar Lal Menariya 
Designation  PG Scholar 
Affiliation  Shubhdeep Ayurved Medical College and Hospital Indore  
Address  G 10, Department of kayachikitsa Shubhdeep Ayurved Medical College and Hospital Indore

Indore
MADHYA PRADESH
452020
India 
Phone  9993105714  
Fax    
Email  drmmenariya@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Deepak Sohgoura 
Designation  Professor 
Affiliation  Shubhdeep Ayurved Medical College and Hospital Indore  
Address  F22, Shubhdeep Ayurved Medical College and Hospital Indore

Indore
MADHYA PRADESH
452020
India 
Phone  8979087079  
Fax    
Email  drdeepaktiwari3.ds@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Umesh Patil 
Designation  Associate Professor 
Affiliation  Shubhdeep Ayurved Medical College and Hospital Indore  
Address  G42, Shubhdeep Ayurved Medical College and Hospital Indore

Indore
MADHYA PRADESH
452020
India 
Phone  9826052986  
Fax    
Email  umeshpatil0704@gmail.com  
 
Source of Monetary or Material Support  
Shubhdeep Ayurved Medical College Indore 
 
Primary Sponsor  
Name  Shubhdeep Ayurved Medical College and Hospital Indore  
Address  Shubhdeep Ayurved Medical College and Hospital Village Datoda Khandwa Road Indore 452020 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR MANOHAR LAL MENARIYA  SHUBHDEEP AYURVED MEDICAL COLLEGE AND HOSPITALINDORE  Room No. 10, Kayachikitsa Department, SAMCH, GRAM DATODA KHANDWA ROAD INDORE
Indore
MADHYA PRADESH 
9993105714

drmmenariya@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICAL COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M543||Sciatica. Ayurveda Condition: GRUDHRASI,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Meshashrungyadi Kashaya, Reference: Vangsen Samhita, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -
(2) Medicine Name: Rasna Guggul, Reference: Bhaisajya Ratnavali, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -Lukewarm Water), Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: Meshashrungyadi Kashaya, Reference: Vangsen Samhita, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 40(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: No, Additional Information: -
3Comparator ArmDrugClassical(1) Medicine Name: Rasna Guggul, Reference: Bhaisajya Ratnavali, Route: Oral, Dosage Form: Gutika/Vati/Ghana Vati/ Tablets, Dose: 500(mg), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 45 Days, anupAna/sahapAna: Yes(details: -LUKEWARM WATER), Additional Information: -
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1. Patients with clinical signs and symptoms of Gridhrasi with back pain radiating to thigh foot will be selected.
2.Patients of either gender with the age group between 20-60 years will be selected.
3. Patients with Positive SLRT are selected.
4.Patients willing to participate in this study and after given their concent. 
 
ExclusionCriteria 
Details  1. Patient not fulfilling the inclusion criteria.
2. Age below 20 years and above 60 years.
3. Patients suffering from the following diseases will be excluded from the study- Spinal Deformity ,Spinal Tumors, Spinal TB, Severe Traumatic Injury, Viral Infection like Poliomyelitis, Carcinoma of the Spine, Congenital abnormalities in spine,Surgical indication. 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
No pain
No pricking sensation
No stiffness
No Twitching
Equally willing towards all food
Normal mental and physical alertness
No heaviness 
45 Days 
 
Secondary Outcome  
Outcome  TimePoints 
NA  NA 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   10/06/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="3"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

  In Ayurveda , various modalities of treatment are explained for the management of Gridhrasi. For a person, to be healthy he should be mentally and spiritually happy. So there is need for safe and effective treatment. Gridhrasi is given as a Vatavyadhi and it is also believed that any type of Pain can not be without presence of Vata. Gridhrasi is a severely painful condition so, Vata Pradhanya in its pathogenesis is clear. In Ayurvedic classics taxts, our Acharyas have given so many special therapeutical procedures for specific disease  along with thousands of medicines.  

 Meshashrungyadi Kashaya And Rasna guggul  both are effective medicine for Gridhrasi because of  its Preventive, Promotive, Prophylactic and Rejuvinative properties as well as providing a radial cure . These two medicine is applicable in all the VatavyadhI.  The disease Gridhrasi as being a Vatavyadhi and Vata is also controller and regulator of other two Dosha , Dhatu and Mala and also all the body activities. Therefore, once Vata is controlled by Meshashrungyadi And Rasna guggul   is also work on Vata-Kaphaja doshas and Aam pachak . Mainly Meshashrungyadi kashaya  is good for Srotorodhajanya Vatavyadhi and Rasna Guggul is for Vatavyadhy.

    It is evident that Meshashrungyadi kashaya is well known and proven that it works for all type of Vatavyadhy’s as Vata shamak chikitsa or Neuro-muscular diseases. Rasna Guggul is works as Kapha-Pitta shamak dosh karmata and also works as Rasyana. So after the combination of both the medicines works as Vata pradhan Tridosh shamak.

     There are 3 comparative groups in my study to diffrentiate and evaluate the efficacy of individual group and combined group for study 60 Patients of  OPD/ IPD of SAMC have been selected irrespective of gender, religion and occupation.        

       Hence I have selects this drugs singly and combined comparatively study to evaluate its efficacy or manage in Gridhrasi( Sciatica) in a well manners.  Hence  I have taken this two medicine Meshashrungyadi kashaya And Rasna guggul  to evaluate its effect in the Gridhrasi (Sciatica Neuritis)

 
Close